<SEC-DOCUMENT>0001193125-23-276662.txt : 20231114
<SEC-HEADER>0001193125-23-276662.hdr.sgml : 20231114
<ACCEPTANCE-DATETIME>20231114074031
ACCESSION NUMBER:		0001193125-23-276662
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		15
CONFORMED PERIOD OF REPORT:	20231108
ITEM INFORMATION:		Results of Operations and Financial Condition
ITEM INFORMATION:		Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20231114
DATE AS OF CHANGE:		20231114

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Alaunos Therapeutics, Inc.
		CENTRAL INDEX KEY:			0001107421
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				841475642
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-33038
		FILM NUMBER:		231401610

	BUSINESS ADDRESS:	
		STREET 1:		8030 EL RIO STREET
		CITY:			HOUSTON
		STATE:			TX
		ZIP:			77054
		BUSINESS PHONE:		(346) 355-4099

	MAIL ADDRESS:	
		STREET 1:		8030 EL RIO STREET
		CITY:			HOUSTON
		STATE:			TX
		ZIP:			77054

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	ZIOPHARM ONCOLOGY INC
		DATE OF NAME CHANGE:	20050919

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	EASYWEB INC
		DATE OF NAME CHANGE:	20010213
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>d349273d8k.htm
<DESCRIPTION>8-K
<TEXT>
<XBRL>
<?xml version="1.0" encoding="utf-8" ?>
<html xmlns:dei="http://xbrl.sec.gov/dei/2022" xmlns:us-types="http://fasb.org/us-types/2022" xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:tcrt="http://alaunos.com/20231108" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:utr="http://www.xbrl.org/2009/utr" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns="http://www.w3.org/1999/xhtml">
<head>
<title>8-K</title>
<meta http-equiv="Content-Type" content="text/html" />
</head>
   <body><div style="display:none"> <ix:header> <ix:hidden> <ix:nonNumeric name="dei:AmendmentFlag" contextRef="duration_2023-11-08_to_2023-11-08">false</ix:nonNumeric> <ix:nonNumeric id="Hidden_dei_EntityCentralIndexKey" name="dei:EntityCentralIndexKey" contextRef="duration_2023-11-08_to_2023-11-08">0001107421</ix:nonNumeric> </ix:hidden> <ix:references> <link:schemaRef xlink:type="simple" xlink:href="tcrt-20231108.xsd" xlink:arcrole="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase"></link:schemaRef> </ix:references> <ix:resources> <xbrli:context id="duration_2023-11-08_to_2023-11-08"> <xbrli:entity> <xbrli:identifier scheme="http://www.sec.gov/CIK">0001107421</xbrli:identifier> </xbrli:entity> <xbrli:period> <xbrli:startDate>2023-11-08</xbrli:startDate> <xbrli:endDate>2023-11-08</xbrli:endDate> </xbrli:period> </xbrli:context> </ix:resources> </ix:header> </div> <div style="text-align:center"> <div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto"> <p style="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&#160;</p> <p style="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&#160;</p> <p style="margin-top:4pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman;font-weight:bold;text-align:center">UNITED STATES</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman;font-weight:bold;text-align:center">SECURITIES AND EXCHANGE COMMISSION</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">Washington, D.C. 20549</p> <p style="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div> <p style="margin-top:8pt; margin-bottom:0pt; font-size:18pt; font-family:Times New Roman;font-weight:bold;text-align:center">FORM <span style="white-space:nowrap"><ix:nonNumeric name="dei:DocumentType" contextRef="duration_2023-11-08_to_2023-11-08">8-K</ix:nonNumeric></span></p> <p style="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div> <p style="margin-top:8pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">CURRENT REPORT</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">Pursuant to Section&#160;13 or 15(d)</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">of the Securities Exchange Act of 1934</p> <p style="margin-top:8pt; margin-bottom:0pt; font-size:12pt; font-family:Times New Roman;font-weight:bold;text-align:center">Date of Report (Date of earliest event reported): <ix:nonNumeric name="dei:DocumentPeriodEndDate" contextRef="duration_2023-11-08_to_2023-11-08" format="ixt:datemonthdayyearen">November&#160;8, 2023</ix:nonNumeric></p> <p style="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div> <p style="margin-top:8pt; margin-bottom:0pt; font-size:24pt; font-family:Times New Roman;font-weight:bold;text-align:center"><ix:nonNumeric name="dei:EntityRegistrantName" contextRef="duration_2023-11-08_to_2023-11-08">Alaunos Therapeutics, Inc.</ix:nonNumeric></p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">(Exact name of registrant as specified in its charter)</p> <p style="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div> <p style="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="border-collapse:collapse; font-family:Times New Roman; font-size:8pt;width:100%;border:0;margin:0 auto">
<tr>
<td style="width:34%"></td>
<td style="vertical-align:bottom"></td>
<td style="width:32%"></td>
<td style="vertical-align:bottom;width:1%"></td>
<td style="width:32%"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold"><ix:nonNumeric name="dei:EntityIncorporationStateCountryCode" contextRef="duration_2023-11-08_to_2023-11-08" format="ixt-sec:stateprovnameen">Delaware</ix:nonNumeric></span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold"><span style="white-space:nowrap"><ix:nonNumeric name="dei:EntityFileNumber" contextRef="duration_2023-11-08_to_2023-11-08">001-33038</ix:nonNumeric></span></span></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><span style="font-weight:bold"><span style="white-space:nowrap"><ix:nonNumeric name="dei:EntityTaxIdentificationNumber" contextRef="duration_2023-11-08_to_2023-11-08">84-1475642</ix:nonNumeric></span></span></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style=" text-align: center;margin:auto; vertical-align:top"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">(State or other jurisdiction</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">of incorporation)</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">(Commission</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">File Number)</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">(IRS Employer</p> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Identification No.)</p></td></tr></table> <p style="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center"><ix:nonNumeric name="dei:EntityAddressAddressLine1" contextRef="duration_2023-11-08_to_2023-11-08">8030 El Rio Street</ix:nonNumeric></p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center"><ix:nonNumeric name="dei:EntityAddressCityOrTown" contextRef="duration_2023-11-08_to_2023-11-08">Houston</ix:nonNumeric>, <ix:nonNumeric name="dei:EntityAddressStateOrProvince" contextRef="duration_2023-11-08_to_2023-11-08">TX</ix:nonNumeric> <ix:nonNumeric name="dei:EntityAddressPostalZipCode" contextRef="duration_2023-11-08_to_2023-11-08">77054</ix:nonNumeric></p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">(Address of principal executive offices, including zip code)</p> <p style="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center"><ix:nonNumeric name="dei:CityAreaCode" contextRef="duration_2023-11-08_to_2023-11-08">(346)</ix:nonNumeric> <span style="white-space:nowrap"><ix:nonNumeric name="dei:LocalPhoneNumber" contextRef="duration_2023-11-08_to_2023-11-08">355-4099</ix:nonNumeric></span></p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">(Registrant&#8217;s telephone number, including area code)</p> <p style="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">Not applicable</p> <p style="margin-top:0pt; margin-bottom:0pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">(Former name or former address, if changed since last report)</p> <p style="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <div style="text-align:center"> <p style="line-height:6.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1.00pt solid #000000;width:21%;text-align:center;margin-left: auto;margin-right: auto">&#160;</p></div> <p style="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Check the appropriate box below if the Form <span style="white-space:nowrap">8-K</span> filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:</p> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top"><ix:nonNumeric name="dei:WrittenCommunications" contextRef="duration_2023-11-08_to_2023-11-08" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top"><ix:nonNumeric name="dei:SolicitingMaterial" contextRef="duration_2023-11-08_to_2023-11-08" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left">Soliciting material pursuant to Rule <span style="white-space:nowrap">14a-12</span> under the Exchange Act (17 CFR <span style="white-space:nowrap">240.14a-12)</span></p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top"><ix:nonNumeric name="dei:PreCommencementTenderOffer" contextRef="duration_2023-11-08_to_2023-11-08" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left"><span style="white-space:nowrap">Pre-commencement</span> communications pursuant to Rule <span style="white-space:nowrap">14d-2(b)</span> under the Exchange Act (17 CFR <span style="white-space:nowrap">240.14d-2(b))</span></p></td></tr></table> <p style="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="border-collapse:collapse; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:4%;vertical-align:top"><ix:nonNumeric name="dei:PreCommencementIssuerTenderOffer" contextRef="duration_2023-11-08_to_2023-11-08" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></td>
<td style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;text-align:left"><span style="white-space:nowrap">Pre-commencement</span> communications pursuant to Rule <span style="white-space:nowrap">13e-4(c)</span> under the Exchange Act (17 CFR <span style="white-space:nowrap">240.13e-4(c))</span></p></td></tr></table> <p style="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Securities registered pursuant to Section&#160;12(b) of the Act:</p> <p style="font-size:8pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="border-collapse:collapse; font-family:Times New Roman; font-size:8pt;width:100%;border:0;margin:0 auto">
<tr>
<td style="width:34%"></td>
<td style="vertical-align:bottom"></td>
<td style="width:32%"></td>
<td style="vertical-align:bottom;width:1%"></td>
<td style="width:32%"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td style=" text-align: center;margin:auto; border-bottom:1.00pt solid #000000;vertical-align:bottom;white-space:nowrap"> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Title of each class</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; border-bottom:1.00pt solid #000000;vertical-align:bottom"> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Trading<br />Symbol(s)</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; border-bottom:1.00pt solid #000000;vertical-align:bottom"> <p style="margin-top:0pt; margin-bottom:1pt; font-size:8pt; font-family:Times New Roman;font-weight:bold;text-align:center">Name of each exchange<br />on which registered</p></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style=" text-align: center;margin:auto; vertical-align:top"><ix:nonNumeric name="dei:Security12bTitle" contextRef="duration_2023-11-08_to_2023-11-08">Common Stock, par value $0.001 per share</ix:nonNumeric></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><ix:nonNumeric name="dei:TradingSymbol" contextRef="duration_2023-11-08_to_2023-11-08">TCRT</ix:nonNumeric></td>
<td style="vertical-align:bottom">&#160;</td>
<td style=" text-align: center;margin:auto; vertical-align:top"><ix:nonNumeric name="dei:SecurityExchangeName" contextRef="duration_2023-11-08_to_2023-11-08" format="ixt-sec:exchnameen">The Nasdaq Stock Market LLC</ix:nonNumeric></td></tr></table> <p style="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#167;230.405 of this chapter) or Rule <span style="white-space:nowrap">12b-2</span> of the Securities Exchange Act of 1934 <span style="white-space:nowrap">(&#167;240.12b-2</span> of this chapter).</p> <p style="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Emerging growth company&#160;&#160;<ix:nonNumeric name="dei:EntityEmergingGrowthCompany" contextRef="duration_2023-11-08_to_2023-11-08" format="ixt-sec:boolballotbox">&#9744;</ix:nonNumeric></p> <p style="margin-top:8pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section&#160;13(a) of the Exchange Act.&#160;&#160;&#9744;</p> <p style="font-size:10pt;margin-top:0pt;margin-bottom:0pt">&#160;</p> <p style="line-height:1.0pt;margin-top:0pt;margin-bottom:0pt;border-bottom:1px solid #000000">&#160;</p> <p style="line-height:3.0pt;margin-top:0pt;margin-bottom:2pt;border-bottom:1px solid #000000">&#160;</p></div></div>

<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />

<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">

<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:11%;vertical-align:top" align="left"><span style="font-weight:bold">Item&#160;2.02</span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:left">Results of Operations and Financial Condition. </p></td></tr></table> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On November&#160;14, 2023, Alaunos Therapeutics, Inc. (the &#8220;Company&#8221;) issued a press release announcing its financial condition and results of operations for the three months ended September&#160;30, 2023. A copy of the press release is furnished as Exhibit 99.1 to this Current Report on Form <span style="white-space:nowrap">8-K.</span> </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">The information contained in this Item 2.02, including Exhibit 99.1, is being &#8220;furnished&#8221; and shall not be deemed &#8220;filed&#8221; for purposes of Section&#160;18 of the Securities Exchange Act of 1934, as amended (the &#8220;Exchange Act&#8221;), or otherwise subject to the liability of that Section or Sections 11 and 12(a)(2) of the Securities Act of 1933, as amended (the &#8220;Securities Act&#8221;). The information contained in this Item 2.02, including Exhibit 99.1, shall not be incorporated by reference into any registration statement or other document pursuant to the&#160;Securities Act&#160;or into any filing or other document pursuant to the&#160;Exchange Act, except as otherwise expressly stated in any such filing. </p> <p style="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:11%;vertical-align:top" align="left"><span style="font-weight:bold">Item&#160;3.01.</span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:left">Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard;&#160;Transfer of Listing. </p></td></tr></table> <p style="margin-top:6pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">As previously disclosed, on January&#160;4, 2023, the Company received a deficiency letter from the Listing Qualifications Department (the &#8220;Staff&#8221;) of The Nasdaq Stock Market LLC (&#8220;Nasdaq&#8221;) notifying the Company that, for the last 30 consecutive business days, the bid price for the Company&#8217;s common stock, par value $0.001 per share (the &#8220;Common Stock&#8221;), had closed below the $1.00 per share minimum bid price requirement for continued inclusion on the Nasdaq Global Select Market pursuant to Nasdaq Listing Rule 5450(a)(1) (the &#8220;Bid Price Requirement&#8221;). In accordance with Nasdaq Listing Rule 5810(c)(3)(A) (the &#8220;Compliance Period Rule&#8221;), the Company was provided an initial period of 180 calendar days, or until July&#160;3, 2023 (the &#8220;Compliance Date&#8221;), to regain compliance with the Bid Price Requirement. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On June&#160;22, 2023, the Company applied to transfer the listing of the Common Stock from the Nasdaq Global Select Market to the Nasdaq Capital Market (the &#8220;Transfer&#8221;). On July&#160;5, 2023, Nasdaq notified the Company that the Transfer was approved, and that, in connection with the Transfer, the Company was eligible for an additional 180 calendar day period, or until January&#160;2, 2024 (the &#8220;Extended Compliance Period&#8221;), to regain compliance with the Bid Price Requirement. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">On November&#160;8, 2023, the Company received a Staff Delisting Determination letter (the &#8220;Delisting Determination&#8221;) from the Staff notifying the Company that, because the closing bid price for the Common Stock was below $0.10 per share for 10 consecutive trading days during the Extended Compliance Period, the Staff has determined to suspend trading of the Common Stock on Nasdaq pursuant to Nasdaq Listing Rule 5810(c)(3)(A)(iii), effective November&#160;17, 2023, and file a Form <span style="white-space:nowrap">25-NSE</span> with the Securities and Exchange Commission (the &#8220;SEC&#8221;) to remove the Common Stock from listing and registration under the Securities Exchange Act of 1934, as amended, unless the Company timely requests an appeal of the Delisting Determination to a Nasdaq Hearings Panel (the &#8220;Panel&#8221;). </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">We intend to timely request a hearing before the Panel to appeal the Delisting Determination and expect a hearing before the Panel to be scheduled where we will seek to remain listed until we are able to consummate a strategic transaction, if ever. Following the hearing, if granted, the Company expects the Panel to issue a written decision that will determine whether the Common Stock will remain listed on Nasdaq. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">A timely request for a hearing ordinarily stays the suspension or delisting of the Common Stock, so the Company expects that the Common Stock will continue to trade on the Nasdaq Capital Market under the symbol &#8220;TCRT&#8221; while the appeal process is pending. </p> <p style="margin-top:12pt; margin-bottom:0pt; text-indent:4%; font-size:10pt; font-family:Times New Roman">There can be no assurance that the Company&#8217;s plan will be accepted by the Panel or that, if it is, the Company will be able to regain compliance with the applicable Nasdaq listing requirements. If the Common Stock is delisted, it could be more difficult to buy or sell the Common Stock or to obtain accurate quotations, and the price of the Common Stock could suffer a material decline. Delisting could also impair the Company&#8217;s ability to raise capital. </p>
</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />

<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold">Forward-Looking Statements </p> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">This Current Report on Form <span style="white-space:nowrap">8-K</span> contains &#8220;forward-looking statements&#8221; within the meaning of the U.S. federal securities laws. Forward-looking statements can be identified by words such as &#8220;projects,&#8221; &#8220;may,&#8221; &#8220;will,&#8221; &#8220;could,&#8221; &#8220;would,&#8221; &#8220;should,&#8221; &#8220;believes,&#8221; &#8220;expects,&#8221; &#8220;anticipates,&#8221; &#8220;estimates,&#8221; &#8220;intends,&#8221; &#8220;plans,&#8221; &#8220;potential,&#8221; &#8220;promise&#8221; or similar references to future periods. Examples of forward-looking statements in this Form <span style="white-space:nowrap">8-K</span> include, without limitation, statements regarding whether the Company will request a review of the Delisting Determination and the timing of the filing of any Form <span style="white-space:nowrap">25-NSE</span> with the SEC. Forward-looking statements are statements that are not historical facts, nor assurances of future performance. Instead, they are based on the Company&#8217;s current beliefs, expectations and assumptions regarding the future of its business, future plans, strategies, projections, anticipated events and trends, the economy and other future conditions. Because forward-looking statements relate to the future, they are subject to inherent risks and uncertainties, and actual results may differ materially from those set forth in the forward-looking statements. Important factors that could cause actual results to differ include, without limitation, delisting from Nasdaq may adversely impact trading in the Common Stock and the Company&#8217;s ability to raise financing; the Company has and expects to continue to incur significant losses; the Company&#8217;s need for additional funding, which may not be available on reasonable terms or at all; and the other important factors described under the caption &#8220;Risk Factors&#8221; in the Company&#8217;s Quarterly Report on Form <span style="white-space:nowrap">10-Q</span> for the quarterly period ended September&#160;30, 2023, filed with the SEC on November&#160;14, 2023, and its other filings with the SEC. Any forward-looking statement made by the Company in this Form <span style="white-space:nowrap">8-K</span> is based only on information currently available and speaks only as of the date on which it is made. Except as required by applicable law, the Company expressly disclaims any obligation to publicly update any forward-looking statements, whether written or oral, that may be made from time to time, whether as a result of new information, future developments or otherwise. </p> <p style="font-size:18pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;border:0;width:100%" cellpadding="0" cellspacing="0">
<tr style="page-break-inside:avoid">
<td style="width:11%;vertical-align:top" align="left"><span style="font-weight:bold">Item&#160;9.01</span></td>
<td align="left" style="vertical-align:top"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:left">Financial Statements and Exhibits. </p></td></tr></table> <p style="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">(d) Exhibits. </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:100%;border:0;margin:0 auto">


<tr>

<td></td>

<td style="vertical-align:bottom;width:5%"></td>
<td style="width:92%"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<td align="center" style="border-bottom:1.00pt solid #000000;vertical-align:bottom;white-space:nowrap"><span style="font-weight:bold">Exhibit</span><br /><span style="font-weight:bold">No.</span></td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:bottom;white-space:nowrap"> <p style=" margin-top:0pt ; margin-bottom:0pt; border-bottom:1.00pt solid #000000; display:table-cell; font-size:8pt; font-family:Times New Roman;font-weight:bold">Description</p></td></tr>


<tr style="font-size:1pt">
<td style="height:6pt"></td>
<td style="height:6pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">99.1</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top"><a href="d349273dex991.htm">Press Release of Alaunos Therapeutics, Inc., dated November&#160;14, 2023. </a></td></tr>
<tr style="font-size:1pt">
<td style="height:6pt"></td>
<td style="height:6pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:top;white-space:nowrap">104</td>
<td style="vertical-align:bottom">&#160;&#160;</td>
<td style="vertical-align:top">Cover Page Interactive Data File (embedded within the Inline XBRL document).</td></tr>
</table>
</div></div>



<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<hr style="color:#999999;height:3px;width:100%" />

<div style="text-align:center"><div style="width:8.5in;text-align:left;margin-left: auto;margin-right: auto">
 <p style="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman;font-weight:bold;text-align:center">SIGNATURE </p> <p style="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. </p> <p style="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&#160;</p>
<table cellspacing="0" cellpadding="0" style="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt;width:100%;border:0">


<tr>

<td style="width:44%"></td>

<td style="vertical-align:bottom;width:1%"></td>
<td style="width:4%"></td>

<td style="vertical-align:bottom"></td>
<td style="width:5%"></td>

<td style="vertical-align:bottom;width:1%"></td>
<td style="width:44%"></td></tr>


<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:0pt">&#160;</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom" colspan="3"><span style="font-weight:bold">Alaunos Therapeutics, Inc.</span></td></tr>
<tr style="font-size:1pt">
<td style="height:12pt"></td>
<td style="height:12pt" colspan="2"></td>
<td style="height:12pt" colspan="2"></td>
<td style="height:12pt" colspan="2"></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:bottom">Date: November&#160;14, 2023</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:0pt">&#160;</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top">By:</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style="margin-top:0pt; margin-bottom:1pt; border-bottom:1px solid #000000; font-size:10pt; font-family:Times New Roman">/s/ Melinda Lackey</p></td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:0pt">&#160;</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top">Name:</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">Melinda Lackey</td></tr>
<tr style="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<td style="vertical-align:bottom"></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom"> <p style=" margin-top:0pt ; margin-bottom:0pt; font-size:0pt">&#160;</p></td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:top">Title:</td>
<td style="vertical-align:bottom">&#160;</td>
<td style="vertical-align:bottom">Senior Vice President, Legal and Administration</td></tr>
</table>
</div></div>

</body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>d349273dex991.htm
<DESCRIPTION>EX-99.1
<TEXT>
<HTML><HEAD>
<TITLE>EX-99.1</TITLE>
</HEAD>
 <BODY BGCOLOR="WHITE" STYLE="line-height:Normal">

<Center><DIV STYLE="width:8.5in" align="left">

<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="51%"></TD>

<TD VALIGN="bottom" WIDTH="1%"></TD>
<TD WIDTH="48%"></TD></TR>


<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top">


<IMG SRC="g349273g1114053540962.jpg" ALT="LOGO">
</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" ALIGN="right"><B>Exhibit 99.1</B></TD></TR>
</TABLE> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Alaunos Therapeutics Announces Third Quarter 2023 Financial Results, Phase 1 Clinical Data and Continued
Exploration of Strategic Alternatives </B></P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><I>TCR-T Library Phase 1/2 trial achieved an 87% disease control rate of eight evaluable patients with
metastatic, refractory solid tumors; <FONT STYLE="white-space:nowrap">TCR-T</FONT> cell therapy was well tolerated in all treated patients</I> </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><I>hunTR</I><I><SUP STYLE="font-size:75%; vertical-align:top">&reg;</SUP></I><I> discovered new HLA class I and
class II restricted TCRs that recognize driver mutations, including KRAS and TP53</I> </P></TD></TR></TABLE> <P STYLE="font-size:6pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" BORDER="0" CELLPADDING="0" CELLSPACING="0" WIDTH="100%">
<TR style = "page-break-inside:avoid">
<TD WIDTH="5%">&nbsp;</TD>
<TD WIDTH="3%" VALIGN="top" ALIGN="left">&#149;</TD>
<TD WIDTH="1%" VALIGN="top">&nbsp;</TD>
<TD ALIGN="left" VALIGN="top"> <P ALIGN="left" STYLE=" margin-top:0pt ; margin-bottom:0pt; font-family:Times New Roman; font-size:10pt"><I>Company continues to explore potential strategic alternatives; cost-savings measures expected to extend cash
runaway into the second quarter of 2024</I><B> </B> </P></TD></TR></TABLE> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>HOUSTON, November</B><B></B><B>&nbsp;14, 2023</B> &#150; Alaunos Therapeutics,
Inc. (&#147;Alaunos&#148; or the &#147;Company&#148;) (Nasdaq: TCRT), today announced financial results for the third quarter ended September&nbsp;30, 2023. As previously announced, the Company is exploring strategic alternatives with Cantor
Fitzgerald&nbsp;&amp; Co. as its strategic advisor. Alaunos continues to reduce spend and cost-savings measures taken to date are expected to extend its cash runway into the second quarter of 2024. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><U>Operational&nbsp;&amp; Corporate Update </U></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Clinical Data from <FONT STYLE="white-space:nowrap">TCR-T</FONT> Library Phase 1/2 Trial: </B>Eight patients were treated and evaluated in the
Company&#146;s <FONT STYLE="white-space:nowrap">TCR-T</FONT> Library Phase 1/2 Trial. Patients with pancreatic (3), colorectal (4)&nbsp;and <FONT STYLE="white-space:nowrap">non-small</FONT> cell lung cancer (1)&nbsp;were treated, with certain of the
pancreatic and colorectal patients also having lung metastases. Overall, the trial showed the Company&#146;s T cells were well-tolerated in all evaluable participants with no dose-limiting toxicities (DLTs) and no immune effector cell-associated
neurotoxicity syndrome (ICANS) were observed. All cytokine release syndrome (CRS) events were within grades <FONT STYLE="white-space:nowrap">1-3</FONT> and were self-limiting or resolved with standard clinical management and, in some cases, a single
dose of tocilizumab. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">One patient with <FONT STYLE="white-space:nowrap">non-small</FONT> cell lung cancer (NSCLC) achieved an objective partial response
with six months progression-free survival. Six other patients achieved best overall response of stable disease. The total overall response rate was 13% and disease control rate was 87% in evaluable patients with advanced, metastatic, refractory
solid tumors (see attached figure). Disease control was measured by objective responses and stable disease. Increased secretion of interferon-gamma relative to baseline was detected in all patients&#146; serum post-cell transfer suggesting
recognition of the tumor by the infused <FONT STYLE="white-space:nowrap">TCR-T</FONT> cells. Persistence of <FONT STYLE="white-space:nowrap">TCR-T</FONT> cells in peripheral blood was detected in all evaluable patients at their last follow-up,
including up to six months in one patient. Infiltration of <FONT STYLE="white-space:nowrap">TCR-T</FONT> cells into the tumor was also detected in three samples where a fresh biopsy was collected suggesting homing to the tumor microenvironment. All
patients have progressed or withdrawn from the trial and long-term <FONT STYLE="white-space:nowrap">follow-up</FONT> is ongoing for a subset of patients with no further intervention per the treatment protocol. This trial established <FONT
STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">proof-of-concept</FONT></FONT> that <I>Sleeping Beauty</I> <FONT STYLE="white-space:nowrap">TCR-T</FONT> cells can result in objective clinical responses and recognize established tumors
<I>in vivo</I>. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Despite the encouraging <FONT STYLE="white-space:nowrap">TCR-T</FONT> Library Phase 1/2 Trial data, based on
the substantial cost to continue development and the current financing environment, Alaunos announced in August 2023 that it would not pursue any further development of its clinical programs. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>hunTR</B><B><SUP STYLE="font-size:75%; vertical-align:top">&reg;</SUP></B><B> TCR Discovery Platform Identifies Proprietary TCRs: </B>Alaunos has
discovered multiple proprietary TCRs targeting driver mutations through its hunTR<SUP STYLE="font-size:75%; vertical-align:top">&reg;</SUP> TCR discovery platform. In addition to TCRs that recognize <I>KRAS </I>and<I> TP53</I> mutations similar to
those licensed from the National Cancer Institute, the Company identified additional TCRs that bind to other driver mutations and TCRs that are restricted to additional HLAs. Alaunos believes that the hunTR<SUP
STYLE="font-size:75%; vertical-align:top">&reg;</SUP> library has the potential to allow for the treatment of a large patient population. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Strategic
Alternatives: </B>The Company continues to explore strategic alternatives, which may include but are not limited to, an acquisition, merger, reverse merger, sale of assets, strategic partnerships, capital raises or other transactions. In connection
with the strategic reprioritization, the Company has reduced its workforce by approximately 80% to date in order to streamline the organization and to maximize its cash runway. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B><U>Third Quarter Ended September&nbsp;30, 2023, Financial Results </U></B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Collaboration Revenue:</B> Collaboration revenue was $0 for the third quarter of 2023, compared to $2.9&nbsp;million for the third quarter of 2022. The
decrease was due to revenue earned under the Solasia License and Collaboration Agreement in 2022 that did not recur in 2023. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Research and Development
Expenses:</B> Research and development expenses were $3.7&nbsp;million for the third quarter of 2023, compared to $7.9&nbsp;million for the third quarter of 2022, a decrease of approximately 54%. The decrease was primarily due to lower program
expenses of $0.8&nbsp;million as a result of our wind-down of clinical activities, a $0.6&nbsp;million decrease in employee-related expenses due to our reduced headcount, an accrual adjustment related to our
<FONT STYLE="white-space:nowrap">de-prioritized</FONT> clinical programs of $0.3&nbsp;million and a $2.5&nbsp;million milestone payment to MD Anderson in 2022 under the terms of our patent and technology license agreement that did not recur in 2023.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>General and Administrative Expenses:</B> General and administrative expenses were $3.6&nbsp;million for the third quarter of 2023, compared to
$3.3&nbsp;million for the third quarter of 2022, an increase of approximately 9%. The increase was primarily due to higher consulting and professional services expenses of $0.9&nbsp;million related to increased legal costs, partially offset by a
$0.4&nbsp;million decrease in employee-related expenses due to our reduced headcount and a $0.2&nbsp;million decrease in insurance fees. </P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Restructuring
Costs:</B> Restructuring costs were $0.4&nbsp;million for the third quarter of 2023, compared to $0 for the third quarter of 2022 due to severance expenses for terminated employees related to our strategic reprioritization announced in August 2023.
</P> <P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Property and Equipment and <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">Right-of-Use</FONT></FONT> Asset Impairment: </B>Property
and equipment and <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">right-of-use</FONT></FONT> asset impairment charges were $1.0&nbsp;million for the third quarter of 2023, compared to $0 for the third quarter of 2022 due to changes
in the intended use of our property and equipment and lease <FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">right-of-use</FONT></FONT> asset following the announcement of our strategic reprioritization in August 2023. </P>
<P STYLE="margin-top:12pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Net Loss:</B> Net loss was $8.5&nbsp;million, or $(0.04) per share, for the third quarter of 2023, compared to a net loss of $8.9&nbsp;million, or $(0.04)
per share, for the third quarter in 2022. </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Cash, Cash Equivalents and Restricted Cash:</B> As of September&nbsp;30, 2023, Alaunos had approximately
$11.9&nbsp;million in cash balances. The Company expects to have sufficient cash resources to fund operations into the second quarter of 2024 as a result of its ongoing strategic reprioritization. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>About Alaunos Therapeutics, Inc. </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">Alaunos Therapeutics is
a <FONT STYLE="white-space:nowrap">T-cell</FONT> receptor (TCR) cell therapy company powered by its hunTR<SUP STYLE="font-size:75%; vertical-align:top">&reg;</SUP> (human neoantigen <FONT STYLE="white-space:nowrap">T-cell</FONT> Receptor) discovery
platform. hunTR<SUP STYLE="font-size:75%; vertical-align:top">&reg;</SUP> enables the rapid identification of wholly owned, proprietary TCRs. Using a proprietary high-throughput TCR screening process, hunTR<SUP
STYLE="font-size:75%; vertical-align:top">&reg;</SUP> enables rapid functional validation of TCRs potentially allowing Alaunos to advance new TCRs from the lab to testing in the clinic. For more information, visit <U>www.alaunos.com</U>. </P>
<P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Forward-Looking Statements Disclaimer </B></P> <P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman">This press release
contains forward-looking statements as defined in the Private Securities Litigation Reform Act of 1995, as amended. Forward-looking statements are statements that are not historical facts, and in some cases can be identified by terms such as
&#147;may,&#148; &#147;will,&#148; &#147;could,&#148; &#147;expects,&#148; &#147;plans,&#148; &#147;anticipates,&#148; &#147;believes&#148; or other words or terms of similar meaning. These statements include, but are not limited to,<U>
</U>statements regarding the Company&#146;s ability to successfully implement its strategic reprioritization or realize any or all of the anticipated benefits once implemented and its ability to successfully consummate any strategic transactions;
the completion and impact of the reduction in workforce; the planned renewed focus on the hunTR<SUP STYLE="font-size:75%; vertical-align:top">&reg;</SUP> TCR discovery platform and its success, including its ability to discover additional TCRs and
the ability to monetize any newly discovered TCRs; the wind down of the <FONT STYLE="white-space:nowrap">TCR-T</FONT> Phase 1/2 Library trial; the Company&#146;s expected cash runway; and the results and potential of the <FONT
STYLE="white-space:nowrap">TCR-T</FONT> Phase 1/2 Library trial and the hunTR<SUP STYLE="font-size:75%; vertical-align:top">&reg;</SUP> discovery platform. Although the management team of Alaunos believes that the expectations reflected in such
forward-looking statements are reasonable, investors are cautioned that forward-looking information and statements are subject to various risks and uncertainties, many of which are difficult to predict and generally beyond the control of Alaunos,
that could cause actual results and developments to differ materially from those expressed in, or implied or projected by, the forward-looking information and statements. These risks and uncertainties include, among other things, risks relating to
volatility and uncertainty in the capital markets for biotechnology and cell therapy companies; availability of suitable third parties with which to conduct contemplated strategic transactions; whether the Company will be able to pursue a strategic
transaction, or whether any transaction, if pursued, will be completed successfully and on attractive terms or at all; whether our cash resources will be sufficient to fund the Company&#146;s foreseeable and unforeseeable operating expenses and
capital requirements; changes in the Company&#146;s operating plans that may impact its cash expenditures; the uncertainties inherent in research and development, future clinical data and analysis; the risks associated with reductions in workforce,
including reduced morale and attrition of additional employees necessary for the strategic reprioritization; the Company&#146;s exclusive focus on its hunTR<SUP STYLE="font-size:75%; vertical-align:top">&reg;</SUP> TCR discovery platform; the
strength and enforceability of Alaunos&#146; intellectual property rights; competition from other pharmaceutical and biotechnology companies; and the potential delisting of the Company&#146;s common stock from the Nasdaq Stock Market LLC, as well as
risk factors discussed or identified in the public filings with the Securities and Exchange Commission made by Alaunos, including those risks and uncertainties listed in the most recent periodic report filed by Alaunos with the Securities and
Exchange Commission. Alaunos is providing this information as of the date of this press release, and Alaunos does not undertake any obligation to update or revise the information contained in this press release whether as a result of new
information, future events, or any other reason. </P> <P STYLE="margin-top:18pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><B>Investor Relations Contact: </B></P>
<P STYLE="margin-top:6pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman"><U>ir@alaunos.com </U></P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt;margin-bottom:0pt">


<IMG SRC="g349273g1114053542380.jpg" ALT="LOGO">
 </P>
</DIV></Center>


<p style="margin-top:1em; margin-bottom:0em; page-break-before:always"> </p>
<HR SIZE="3" style="COLOR:#999999" WIDTH="100%" ALIGN="CENTER">

<Center><DIV STYLE="width:8.5in" align="left">
 <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Alaunos Therapeutics, Inc. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Statement of Operations </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">(In
thousands except per share data) </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="78%"></TD>

<TD VALIGN="bottom" WIDTH="6%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="6%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="6" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000">For the Three Months Ended<br>September&nbsp;30<br>(Unaudited)</TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000">2023</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000">2022</TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Collaboration revenue</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">2,911</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Operating expenses:</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD>
<TD VALIGN="bottom"></TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Research and development</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">3,656</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">7,893</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">General and administrative</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">3,578</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">3,282</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Restructuring costs</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">419</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Property and equipment and
<FONT STYLE="white-space:nowrap"><FONT STYLE="white-space:nowrap">right-of-use</FONT></FONT> asset impairment</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">1,011</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total operating expenses</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">8,664</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">11,175</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Loss from operations</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(8,664</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(8,264</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Interest expense</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(841</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Other income, net</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">188</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">254</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Net loss</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(8,476</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(8,851</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Basic and diluted net loss per share</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(0.04</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">(0.04</TD>
<TD NOWRAP VALIGN="bottom">)&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Weighted average common shares outstanding, basic and diluted</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">240,046,026</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">215,098,995</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE> <P STYLE="margin-top:24pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center"><B>Alaunos Therapeutics, Inc. </B></P>
<P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">Selected Balance Sheet Data </P> <P STYLE="margin-top:0pt; margin-bottom:0pt; font-size:10pt; font-family:Times New Roman" ALIGN="center">(In
thousands) </P> <P STYLE="font-size:12pt;margin-top:0pt;margin-bottom:0pt">&nbsp;</P>
<TABLE CELLSPACING="0" CELLPADDING="0" WIDTH="100%" BORDER="0" STYLE="BORDER-COLLAPSE:COLLAPSE; font-family:Times New Roman; font-size:10pt" ALIGN="center">


<TR>

<TD WIDTH="82%"></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD>

<TD VALIGN="bottom" WIDTH="4%"></TD>
<TD></TD>
<TD></TD>
<TD></TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:8pt">
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000">September&nbsp;30,<br>2023<br>(Unaudited)</TD>
<TD VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD VALIGN="bottom" COLSPAN="2" ALIGN="center" STYLE="border-bottom:1.00pt solid #000000">December&nbsp;31,<br>2022<br>(Audited)</TD>
<TD VALIGN="bottom">&nbsp;</TD></TR>


<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Cash and cash equivalents</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">11,944</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">39,058</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Restricted cash</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">&#151;&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">13,938</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Working capital, excluding restricted cash</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">8,193</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">15,695</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total assets</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">19,440</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">64,937</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
<TR BGCOLOR="#cceeff" STYLE="page-break-inside:avoid ; font-family:Times New Roman; font-size:10pt">
<TD VALIGN="top"> <P STYLE=" margin-top:0pt ; margin-bottom:0pt; margin-left:1.00em; text-indent:-1.00em; font-size:10pt; font-family:Times New Roman">Total stockholders&#146; equity</P></TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">13,900</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD>
<TD VALIGN="bottom">&nbsp;&nbsp;</TD>
<TD NOWRAP VALIGN="bottom">$</TD>
<TD NOWRAP VALIGN="bottom" ALIGN="right">38,555</TD>
<TD NOWRAP VALIGN="bottom">&nbsp;</TD></TR>
</TABLE>
</DIV></Center>

</BODY></HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>3
<FILENAME>tcrt-20231108.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii"?>
<!-- DFIN - https://www.dfinsolutions.com/ -->
<!-- CTU Version: Release master Build:20221108.6 -->
<!-- Creation date: 11/14/2023 3:08:29 PM Eastern Time -->
<!-- Copyright (c) 2023 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<xsd:schema
  xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric"
  xmlns:num="http://www.xbrl.org/dtr/type/numeric"
  xmlns:us-types="http://fasb.org/us-types/2022"
  xmlns:tcrt="http://alaunos.com/20231108"
  xmlns:dei="http://xbrl.sec.gov/dei/2022"
  xmlns:xbrli="http://www.xbrl.org/2003/instance"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xbrldt="http://xbrl.org/2005/xbrldt"
  attributeFormDefault="unqualified"
  elementFormDefault="qualified"
  targetNamespace="http://alaunos.com/20231108"
  xmlns:xsd="http://www.w3.org/2001/XMLSchema">
    <xsd:import schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" namespace="http://www.xbrl.org/2003/instance" />
    <xsd:import schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" namespace="http://www.xbrl.org/2003/linkbase" />
    <xsd:import schemaLocation="https://xbrl.sec.gov/dei/2022/dei-2022.xsd" namespace="http://xbrl.sec.gov/dei/2022" />
    <xsd:import schemaLocation="http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd" namespace="http://www.xbrl.org/dtr/type/numeric" />
    <xsd:import schemaLocation="http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd" namespace="http://www.xbrl.org/dtr/type/non-numeric" />
    <xsd:import schemaLocation="https://xbrl.sec.gov/naics/2022/naics-2022.xsd" namespace="http://xbrl.sec.gov/naics/2022" />
    <xsd:import schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd" namespace="http://xbrl.org/2005/xbrldt" />
  <xsd:annotation>
    <xsd:appinfo>
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="tcrt-20231108_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:title="Label Links, all" xlink:type="simple" />
      <link:linkbaseRef xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="tcrt-20231108_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:title="Presentation Links, all" xlink:type="simple" />
      <link:roleType roleURI="http://alaunos.com//20231108/taxonomy/role/DocumentDocumentAndEntityInformation" id="Role_DocumentDocumentAndEntityInformation">
        <link:definition>100000 - Document - Document and Entity Information</link:definition>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xsd:appinfo>
  </xsd:annotation>
</xsd:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>4
<FILENAME>tcrt-20231108_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii" standalone="yes"?>
<!-- DFIN - https://www.dfinsolutions.com/ -->
<!-- CTU Version: Release master Build:20221108.6 -->
<!-- Creation date: 11/14/2023 3:08:29 PM Eastern Time -->
<!-- Copyright (c) 2023 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<link:linkbase
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink"
  xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
  xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CoverAbstract" xlink:type="locator" xlink:label="dei_CoverAbstract" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CoverAbstract" xlink:to="dei_CoverAbstract_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_CoverAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Cover [Abstract]</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_CoverAbstract_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Cover [Abstract]</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentFlag" xlink:type="locator" xlink:label="dei_AmendmentFlag" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_AmendmentFlag_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Amendment Flag</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_AmendmentFlag_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Amendment Flag</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCentralIndexKey" xlink:type="locator" xlink:label="dei_EntityCentralIndexKey" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityCentralIndexKey_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Central Index Key</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityCentralIndexKey_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Central Index Key</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentType" xlink:type="locator" xlink:label="dei_DocumentType" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_DocumentType_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Document Type</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_DocumentType_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document Type</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodEndDate" xlink:type="locator" xlink:label="dei_DocumentPeriodEndDate" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_DocumentPeriodEndDate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Document Period End Date</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_DocumentPeriodEndDate_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Document Period End Date</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityRegistrantName" xlink:type="locator" xlink:label="dei_EntityRegistrantName" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityRegistrantName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Registrant Name</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityRegistrantName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Registrant Name</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityIncorporationStateCountryCode" xlink:type="locator" xlink:label="dei_EntityIncorporationStateCountryCode" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Incorporation State Country Code</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Incorporation State Country Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFileNumber" xlink:type="locator" xlink:label="dei_EntityFileNumber" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityFileNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity File Number</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityFileNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity File Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityTaxIdentificationNumber" xlink:type="locator" xlink:label="dei_EntityTaxIdentificationNumber" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Tax Identification Number</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Tax Identification Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine1" xlink:type="locator" xlink:label="dei_EntityAddressAddressLine1" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressAddressLine1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, Address Line One</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressAddressLine1_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, Address Line One</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCityOrTown" xlink:type="locator" xlink:label="dei_EntityAddressCityOrTown" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressCityOrTown_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, City or Town</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressCityOrTown_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, City or Town</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressStateOrProvince" xlink:type="locator" xlink:label="dei_EntityAddressStateOrProvince" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressStateOrProvince_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, State or Province</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressStateOrProvince_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, State or Province</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressPostalZipCode" xlink:type="locator" xlink:label="dei_EntityAddressPostalZipCode" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressPostalZipCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Address, Postal Zip Code</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityAddressPostalZipCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CityAreaCode" xlink:type="locator" xlink:label="dei_CityAreaCode" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_CityAreaCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">City Area Code</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_CityAreaCode_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">City Area Code</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LocalPhoneNumber" xlink:type="locator" xlink:label="dei_LocalPhoneNumber" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_LocalPhoneNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Local Phone Number</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_LocalPhoneNumber_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Local Phone Number</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_WrittenCommunications" xlink:type="locator" xlink:label="dei_WrittenCommunications" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_WrittenCommunications_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Written Communications</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_WrittenCommunications_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Written Communications</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SolicitingMaterial" xlink:type="locator" xlink:label="dei_SolicitingMaterial" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_SolicitingMaterial_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Soliciting Material</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_SolicitingMaterial_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Soliciting Material</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementTenderOffer" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Pre Commencement Tender Offer</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Pre Commencement Tender Offer</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementIssuerTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementIssuerTenderOffer" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Pre Commencement Issuer Tender Offer</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Pre Commencement Issuer Tender Offer</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12bTitle" xlink:type="locator" xlink:label="dei_Security12bTitle" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_Security12bTitle_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Security 12b Title</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_Security12bTitle_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Security 12b Title</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_TradingSymbol" xlink:type="locator" xlink:label="dei_TradingSymbol" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_TradingSymbol_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Trading Symbol</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_TradingSymbol_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Trading Symbol</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityExchangeName" xlink:type="locator" xlink:label="dei_SecurityExchangeName" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_SecurityExchangeName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Security Exchange Name</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_SecurityExchangeName_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Security Exchange Name</link:label>
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityEmergingGrowthCompany" xlink:type="locator" xlink:label="dei_EntityEmergingGrowthCompany" />
    <link:labelArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" />
    <link:label xml:lang="en-US" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label">Entity Emerging Growth Company</link:label>
    <link:label xml:lang="en-US" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/terseLabel">Entity Emerging Growth Company</link:label>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>5
<FILENAME>tcrt-20231108_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii" standalone="yes"?>
<!-- DFIN - https://www.dfinsolutions.com/ -->
<!-- CTU Version: Release master Build:20221108.6 -->
<!-- Creation date: 11/14/2023 3:08:29 PM Eastern Time -->
<!-- Copyright (c) 2023 Donnelley Financial Solutions, Inc. All Rights Reserved. -->
<link:linkbase
    xmlns:link="http://www.xbrl.org/2003/linkbase"
    xmlns:xlink="http://www.w3.org/1999/xlink"
    xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"
    xmlns:xbrldt="http://xbrl.org/2005/xbrldt"
    xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://alaunos.com//20231108/taxonomy/role/DocumentDocumentAndEntityInformation" xlink:href="tcrt-20231108.xsd#Role_DocumentDocumentAndEntityInformation" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://alaunos.com//20231108/taxonomy/role/DocumentDocumentAndEntityInformation">
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CoverAbstract" xlink:type="locator" xlink:label="dei_CoverAbstract" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_AmendmentFlag" xlink:type="locator" xlink:label="dei_AmendmentFlag" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_AmendmentFlag" order="22.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityCentralIndexKey" xlink:type="locator" xlink:label="dei_EntityCentralIndexKey" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityCentralIndexKey" order="23.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentType" xlink:type="locator" xlink:label="dei_DocumentType" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentType" order="25.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_DocumentPeriodEndDate" xlink:type="locator" xlink:label="dei_DocumentPeriodEndDate" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_DocumentPeriodEndDate" order="26.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityRegistrantName" xlink:type="locator" xlink:label="dei_EntityRegistrantName" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityRegistrantName" order="27.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityIncorporationStateCountryCode" xlink:type="locator" xlink:label="dei_EntityIncorporationStateCountryCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityIncorporationStateCountryCode" order="28.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityFileNumber" xlink:type="locator" xlink:label="dei_EntityFileNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityFileNumber" order="29.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityTaxIdentificationNumber" xlink:type="locator" xlink:label="dei_EntityTaxIdentificationNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityTaxIdentificationNumber" order="30.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressAddressLine1" xlink:type="locator" xlink:label="dei_EntityAddressAddressLine1" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressAddressLine1" order="31.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressCityOrTown" xlink:type="locator" xlink:label="dei_EntityAddressCityOrTown" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressCityOrTown" order="32.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressStateOrProvince" xlink:type="locator" xlink:label="dei_EntityAddressStateOrProvince" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressStateOrProvince" order="33.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityAddressPostalZipCode" xlink:type="locator" xlink:label="dei_EntityAddressPostalZipCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityAddressPostalZipCode" order="34.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_CityAreaCode" xlink:type="locator" xlink:label="dei_CityAreaCode" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_CityAreaCode" order="35.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_LocalPhoneNumber" xlink:type="locator" xlink:label="dei_LocalPhoneNumber" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_LocalPhoneNumber" order="36.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_WrittenCommunications" xlink:type="locator" xlink:label="dei_WrittenCommunications" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_WrittenCommunications" order="37.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SolicitingMaterial" xlink:type="locator" xlink:label="dei_SolicitingMaterial" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_SolicitingMaterial" order="38.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementTenderOffer" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_PreCommencementTenderOffer" order="39.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_PreCommencementIssuerTenderOffer" xlink:type="locator" xlink:label="dei_PreCommencementIssuerTenderOffer" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_PreCommencementIssuerTenderOffer" order="40.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_Security12bTitle" xlink:type="locator" xlink:label="dei_Security12bTitle" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_Security12bTitle" order="41.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_TradingSymbol" xlink:type="locator" xlink:label="dei_TradingSymbol" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_TradingSymbol" order="42.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_SecurityExchangeName" xlink:type="locator" xlink:label="dei_SecurityExchangeName" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_SecurityExchangeName" order="43.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
    <link:loc xlink:href="https://xbrl.sec.gov/dei/2022/dei-2022.xsd#dei_EntityEmergingGrowthCompany" xlink:type="locator" xlink:label="dei_EntityEmergingGrowthCompany" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="dei_CoverAbstract" xlink:to="dei_EntityEmergingGrowthCompany" order="44.001" priority="2" use="optional" preferredLabel="http://www.xbrl.org/2003/role/terseLabel" />
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>6
<FILENAME>g349273g1114053540962.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g349273g1114053540962.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1"  P ,L# 2(  A$! Q$!_\0
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'%%%% '__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>7
<FILENAME>g349273g1114053542380.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 g349273g1114053542380.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" $) @0# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH ^=7US2)/&/B2'Q/XW\4:9Y-Z5M8=/
MNIMFS'/"JP'/TKK/A_XQ-AX>\2:K?ZS=:EX>T^;%E/=-ON64#HPX;D_WOY4_
M2;/QUX3\2>(Y[#PA'J=KJ5YY\<K:G%#@8QT.3_*HXOASKWB"T\5WNK16ND7>
MMQJD5G#()%C*G.YV'!)]10!T.D_$>YFU;3[/7/#L^DQ:H2+"<W"3"7C.&"\H
M<=C5&U^*M_J=Y<R:5X1N[[2K:<P33PW*&<$'!(@'S$5D^#OAV;#6;26\^']A
M826A!_M$:S))N8#[RQC/7T.*K^(O!7BK4-2G:V\+:5#J<DA,.OZ??M:^6"<Y
M>+.6..O6@"_XL\7>*[3XK:)IFF:=)+8RV_FI:&Y2+[1GJS$C*[>FT]<5U7Q/
MO;NQ^&&M7=K/+:W20*RR0R%70[USAAS6)XC\,^)H_%_ACQ%IUM%JLUA;?9KJ
M-IUA))/+Y;KU],UT?Q"TB_\ $'P^U;3-/@$E]<PJL<6\*"=RDC)P.QH \H>7
M1K/P6NL6WQ2UDZXEL)5M6UE9@9<?=,6,GZ&NYC^(6IVNB^'[+^Q9=1\4:C9+
M<O9AUMU0#JSLWW>>U4M3^%P?P=I=QHUC:Z=XJTV-)(I851/,D ^97(X;/J:H
M>*_!&M^*IM'\1:CX:M[Z\@M3;WFCS7PBW'.0Z2H<=SP3T[4 =(WQ3L;?PGJF
ML7FFW4%WI<WV>ZL<JS+)Z!AP5]ZN>%_&6LZSJ*VFJ^%+G3DEB\Z&ZAG6Z@9?
M1G485O:L?2/!EWIW@W4(=*\*:-I-]=LI>QN[N2]BE4=G)P ?3&1Q^6?X.\(>
M(K+QE;ZE'HD?A?3(U?[790ZC]I2[8C@A!PF#@_AB@!UA\8-8U30[K6+/P1<3
M65E*RW<JWJ81%ZLH(!<@<D8P/6NDU3XCV5OIFBS:393ZI?:VNZPLXR$+C;DE
MF/"@=S]?0UY=\/5\87/P\U?2]%TJRO;/4+B>W,\EUY36VX;6)4CYASQ@YKL;
MKX=:MHEMX1U#0?L][J7AZ)HY+>9S&MR&4AMK?PG+-C/K[4 :]M\27%MK=OJN
MB2Z=KFDV37KV$DZNLL8&<I(HP1T!..,UDP_%^^.FZ-K%UX0NK;1=0F2!KQKI
M"4=LCY4 W,O!Y.W(ILG@_P 2Z_<>(_$>L64%GJ5YI$FG6.G0W"R;0P_C?A<D
M@8[<FI-1\':Y<?"#0-!BLP=2M)+9IHO-0;0A^;YLX./8T 7]7^)-_#XJOM!T
M'PS)JLVGHKW3->) <,H8>6IR7X[#O]:T-8^("Z=I>C/!HM]-J^L%EM-+F'D2
M!E&6\PMPH'&3SUR,CFN=\;^%M;U77)IF\':3K<!V&SNX;PV=U;D#K(V?GP>F
M/3\L_7/AEK^I^%?"YU,P:]J6CF7[3:3W+1BYC?D*)>#N7"C)Z]_< [SPGXQ/
MB&[U#3+[39-,UC3MAN;1Y5E4!QE65UX85R7Q+\4^*=&\>>%=.T:S:6UN79O*
M6Y2/[:X*YC)(R@48.>AW^U;/PY\)Q:$;J]/A"V\/7$RB/9%J3W;.H.><_*.V
M,$GZ5'\1O#NN:AKGA?7]"LX[^?1KB1WM'F6(R!]G1FX&-GZT 6-4\>ZA%K/]
MA:'X<EU;6(+=)[V!;I(H[;< =ID/!;G@8Y%;7A'Q9:>+M+ENK>&:VGMYVMKJ
MVG&'AE7JI]?K7)7.B>+/#OC34?$^A:3::HFL6\(NK)[L1/#*BXRK$8*X'U.>
MU;?P\\*7OAJPU*XU1X6U+5;Z2]N%@R4C+'(0$]<9//O^- &!\6-!GMO#^J^)
M[/Q)X@L[F")2EM;7YCMP00/N 9_6LF:6Z\!?#BW\50:]K6HZEJ5E;QI%J5Z9
MH8Y)=C%U4CJ.<<].*[[XBZ/?:_X#U73--A$UY<1!8T+A<G(/4D"J&I^"7\0_
M"W3_  Y=N+6]@L[<!^&$<T:KUQU&1@X[4 4)/AYXAB@2]LO'NM#63M,C7$@D
MM2>-V(<8 ]*YCQA<M+\7+72=;\87^BZ?_9*22R6=^;.-I<OR 20,XZ<GWKJ'
MO_BG<0+IL6A:5:7"[5;57O1)$^,9(B W#/O4-YX'O-5^+-KK&L:;9W^E)I2V
M\LLJ(4:8%LXC8DCK_P#7H R?"VIO8_$VTT70/%5]XCT6>UDDNWN;@77D,!\I
M$H&!DX&/\:]4U;3AJVF3V)N[NT$R[?/M)?+E3W5NQKA-%\*:SX+\;3PZ)9^=
MX4U/YY8UF16LI3U90Q!*^PS^@KH]!\&QZ#JDU\NO:]?&52/)O[WS8ER<\+@8
MH \TL?"MU<_%'4?#+^,O%HL;:Q2X1QJK>86+8Y.,8_"O:K2W^R6<-L)99O*0
M)YDS;G? QECW/O7&:?X=U2#XOZIKTEN!IL^GI!'+YBG+ALD;<Y_2NYH ****
M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@
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M8O&NM>#;+27T5X%DNIVC?S4W# ''>@"G_P +2\7_ /1.M2_7_"C_ (6EXO\
M^B=:E^O^%<#_ ,+:^(?_ #WTW_OQ_P#7H_X6U\0_^>^F_P#?C_Z]5R2["YD=
M]_PM+Q?_ -$ZU+]?\*Q+C4_$_C+X@^%[N[\(W^FV]A.Q>2121@@\DXXKG/\
MA;7Q#_Y[Z;_WX_\ KU:T7XM>-YO$^DV-_+8F"[N5C<)#@X)Y[TG%H+H^BI8H
MYHVCEC62-NJN,@_A3MHV[<#;C&,4$A5+,0 !DD]JH66N:7J-Q);V=]#--&2&
M16Y&*0R2+2=-AB,46GVL<;9RB0J <G)XQZU.;6W+NY@B+2($=M@RRCH#ZCD\
M>]+<3Q6MM+<3R+'#$A>1V. J@9)/X4L4L<\*2Q.'C<!E8="#0!!;Z;86BQK;
M65M"L9+((XE4*3U(P.,T[[!9_;?MOV2#[7MV^?Y8WX]-W7%6** *T.G6-M*T
ML%E;Q2.Y=G2)5)8]22!U/K1#IMC;[O(LK>+<NQMD2KE22<<#IDD_B:G+HKJA
M8!F^Z">345Y>6^GV<UW=S)#;PJ7DD<X"J.I- !:65K80>39VT-O$#GRX8PBY
M^@J>@$$9'0T4 %%%% !1139&*1.ZH7902%'4^U ''^(;_P 06GB*V6VANY+!
MR5/V6W\P*OE2?,Q]?,,?'H":Z72&O7T:Q;4A&+XP(;@1_=$FT;L>V<UGOK.I
M-&P'A^[R00/WB?XU/X6M+JP\)Z1:7V?M<%G%'-ELG>% //?F@#6HK$N/%>E6
MU[<VLDLFZUC:29Q&2B!=NX$^H#J<>AK:5@ZAE.5(R".] "T444 %%5KR^M["
M)9+A]H9@J@ DDGL*JGQ!I8L([S[4IAD8HI Y+#J,=<C!H TZX;QO_P C?X+_
M .PBW_H!KM;>>*ZMX[B!Q)%(H9&'0@]*XKQO_P C?X+_ .PBW_H!H [FO(/@
M;_Q^>-/^PL?YO7K]>0? W_C\\:?]A8_S>@#U^O(/CO\ =\(_]A9?Z5Z_7D'Q
MW^[X1_["R_TH ]?K*\0ZNVBZ:MRD:NSRK$"Y(1-W\3$= *U:H:O#>36BK9"!
MR'!DBG7*RIW7VH P[_Q'J6GZ#>7KV]I,\31B&6&4M%(&8+UZ@C-78-7O[;6[
M73M3AMP+R-FMY8&)Y4 L&!'N*P;[PE?W-GJ?V2""S6X6$162/\FY'#%CV!(&
M.*W$TZ^U#7K'4;Z".WBL8W$48?<S.^ 2<<8P* .@HHHH **KK?VCSF!+F)I0
M<; XSGTJ-=5T]Y?*6\A+[MF-X^]Z?6@"Y1110 4444 %%%% !1110 4444 %
M%%% !1110 4444 %%%% !1110 4444 %%%% !7B?[1/_ !X^'/\ K[?_ -!%
M>V5X]\>](U/5-/T,Z;83W;0W+NZQ+G VBA >244?V7XI_P"A8O\ _OV:/[+\
M4_\ 0L7_ /W[-='/$QY&%+IO_([^&_\ K]7^8I/[+\4_]"Q?_P#?LU<T'0/$
MD_C'0YI] O8(H+M&=VC. ,]:F4TT.,6F?2WBV.YE\*Z@EK_K#&,@ G*;AO''
MJNZHH[_19)=+CMQ%/<A2+<1#)B&WG./NCH.?:M^J\%A9VLLDMO:00R2'+O'&
M%+?4CK6)J>:W.L7USX:F>;47GEO](O)+NT8#%NRQ\8 Y7J1SUJP-6O8K1V&H
MR6;6$-J+.V7&V[W(A.01ELDE>.F,UZ$+"S5YG%I &G&)2(QF0>C>OXT/8V<D
MD,CVD#20_P"J8Q@F/_=/;\* .#N=6UF#3?$.IQ7=Q++!?+:PVXVA(HRZ!CTZ
M@,W).!^%%OK.K#2KJ*>\>&#[;#"+MYXYI(8W W99/ESG@'MN'I7H MX0LBB&
M,+(27&T?,3USZU%'I]E#:-:16=NELV=T*Q*$.>N1C% '"WA2'QGX<F&M7%Y%
M;P7P,FY3N($1"G PQP3TZX%<YJ>N7U[X;\16T]U/-;W&@O=J)Y$<JVXCC;PH
M(Q\I)(KUY+"SCCAC2T@5(3F)5C "'U4=OPIB:5IT<;1I86JQL"K*(5 (/4$8
M[X&: +$7^J3_ '13Z** "BBB@ HHHH Y0ZQXBAU"Y@NK?284!S;[[D@N@7+'
M'H.?RKI+,SFR@-T8S<&-3(8ON[L<X]LUP/BL:*/% FN-7B@NX!O>.2U,NU6B
MDCQG'W2')QTRM='H>K:4/#$::3?+=PV%ND6^0G<0% !;(SR!UH RKZVTJ^U>
M^,>E:E/MD:*Y,)(CD8JFX?D$SCTKM4QY:X7:,#"^GM7!3C2I-1N+I @>X</(
M5N)%W-@#./P_2N\B_P!2F.FT4 /HHHH RM?UF/1;))C$99Y9!%!'ZN>F3V'J
M:YA88M,GT6\NI5N%,]P]Q<1@[(Y7C/Z?PBNZ>-)!AT5@.S#-((HPFP1H%Z[=
MO% '*Z5_;EEX'M#IEK!<WK,[K'<R%%\MI&8<_P"Z17*ZQ=>)I_&WA :[IUA:
MQ"^)C:VG,A)V'@Y%>KUPWC?_ )&_P7_V$6_] - '<UY!\#?^/SQI_P!A8_S>
MO7Z\@^!O_'YXT_["Q_F] 'K]>0?'?[OA'_L++_2O7Z\@^._W?"/_ &%E_I0!
MZ_7EGQ*\8^*]'\9:'H'AC[&9M2B8A;A 06!/?/' KU.O(/'O_)=O ?\ NM_-
MJ #S/CG_ ,\="_-?\:AN[[XW65E/=S0Z&(H(VD<C:3M49/?VKV6LOQ)_R*VK
M_P#7E-_Z : ,#X6^)M1\7>!K?5]4,1NI)9$8Q)M7"M@<5V1. 3Z5YI\!O^25
MV?\ U\3?^AFNR\4^*M,\'Z1_:FK/(EMYBQ9C3>=QSCC\* .5MA%H]K8O$]EJ
M6EFZ'E2+\MTCLV/^!8SSWZU6MQ:_\*YUXN(OM7VR\^SGC?YOFMY>WOG=C%4D
M^-/PVCN//1)UEW;MPLCG=Z_7WIB_&3X9I+YJQSA]^_/V(_>]?K[T >K6?F?8
M;?SO]9Y:[\^N.:GKE?"'Q"T#QO+=QZ++.[6JJTOFQ%,!LXQ^1KJJ .9U37I[
M?Q VF_:+>R06ZS12W"G;,Q+ KGH ,#WYJ&/5]9OO$D>F(T%GC3(KN0;1)\[.
MZD ^GR]:T=4L-3GN)O)%A=6DJ8\B\0D(P&,C'4'O618>%]5T75+>ZL9[6=8]
M,CLF\_<#N1W;(QV^?]* -WP_J<VIV,OVI(TN[:>2WG$9RNY#C(]B,'\:U:R]
M"TN32K&1)Y1-<SS/<3NHP"[L20/8=!["M2@ HHHH **** "BBB@ HHHH ***
M* "BBB@ HHHH **** "BBB@ KSOXJ^--8\(0Z0-&B@DGOK@PXF&1TXKT2O(/
MCC_Q]^$/^PC_ $%)NR&E=V*7_"7_ !9_Z!&F?]]"C_A+_BS_ - C3/\ OH5V
M=%<'UJ9ZGU*GYG&?\)?\6?\ H$:9_P!]"ETWXB^.H/&6C:1KUC8PPW\NW,8R
M<8-=E7"^)/\ DJ?@O_KLW\C6E*O*<[,QKX6%.#DCVR\O+?3[26[NYEAMXAN>
M1S@*/>C[9;;H%\Y-UP"8AG[X'/'YUE^+D63PO>QNH9&"*P/0@NM<W:>9I'BG
M1]#E$CPQ)-+9R8SF(A?DSZJ>/IBNPX#KHM>TJ?4&L([V)KE3@H#W] >A-%SK
MVE6=ZMG<7L4=PQP$)Z?7L/QKB[2>&PM-/2PNH-4L3=)Y5E,FVYM]S8R.^5R2
M<]@:NZ1<:=9:1KMIK9C-P]Y=-/"_WYD9V*;1U;*%<8]J .QCO+>:ZFMHYE:>
M$*9$!Y4-R,_6JU]K>F:;.D%Y>1Q2/]U3G/XXZ?C7/:9J%C:>--;\^YAME:"V
M*+-($.-A]34FG75E8:IXA&K2PQR37.\&8@"6$QJ%"YZC&1@=P: .L5@RAE(*
MD9!'>EJGI)@;2+,VL#P6YA7RXG!#(N. <]ZN4 %%%% !1110 4444 <AJ4VF
M)K]^AU>>PN'2,7";<K(N#@CCC@D?A6KHFAV&G,;NR=GCEM8+>/<<@11!M@]_
MOL<GUK \23^(TUUQ:"2.P 50T5BDQY1CN))S]Y0I';(-=5H<EW+H.GR7\9CO
M'MHVG0J!M<J-PP.!SF@#E]4U/Q!;:Q?)!;R&,1NMK$EJ&5F&PJQ;WRX/IBNU
M3<8U+@!L#('8UQ6HZ/XCNM1OMCL+<.\MNPN,$N418QCL%.\D=SBNUC#+$@=M
MSA0&/J: '4444 %%%5+_ %.TTR-'NI=F]MJ #)8]> /:@"W7#>-_^1O\%_\
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M'RD_<Q_='\(I_P!G@_YXQ_\ ?(I8O]2G^Z*?74<YW_[/("^(O%8   $. /\
M>>O?:\"_9[_Y&/Q9](?_ $)Z]]KF>YNMCPSX;P>*O'FEZC?W'CC5K,V]ZUNJ
M1*C @*ISR/\ :KM/^%?^(O\ HHVN?]^X_P#"N?\ V>O^15UO_L+/_P"@)7K]
M(9XCXK'B?P5XL\'VZ^,M3U"#5-16*:.=44;0\8(X'<.:]NKR#XR?\CI\./\
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M9[?1'BLX'F=5+Y(49.*\]M?CIXGNK9)TTK30KC@%GKUSXB_\DW\2?]@Z;_T
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M\F;F,L K2,P!&0<X85RFMP^)(O&W@\ZY>6$\1OCY8MH2A!V'KDFO5:X;QO\
M\C?X+_["+?\ H!H [FBBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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M!^)( JC<>)4M;>V,FG7PNKB5HX[/:GF$J"6.=VW 4$YS^O% &Y7#>-_^1O\
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M !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444
M%%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4444 %%%% !1110 4
&444 ?__9

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>8
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm139969406094736">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Document and Entity Information<br></strong></div></th>
<th class="th"><div>Nov. 08, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001107421<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Nov.  08,  2023<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">Alaunos Therapeutics, Inc.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation State Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-33038<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">84-1475642<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">8030 El Rio Street<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Houston<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">TX<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">77054<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">(346)<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">355-4099<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre Commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre Commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Security 12b Title</a></td>
<td class="text">Common Stock, par value $0.001 per share<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">TCRT<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Section 14a<br> -Number 240<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>9
<FILENAME>d349273d8k_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2022"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="tcrt-20231108.xsd" xlink:type="simple"/>
    <context id="duration_2023-11-08_to_2023-11-08">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001107421</identifier>
        </entity>
        <period>
            <startDate>2023-11-08</startDate>
            <endDate>2023-11-08</endDate>
        </period>
    </context>
    <dei:AmendmentFlag contextRef="duration_2023-11-08_to_2023-11-08">false</dei:AmendmentFlag>
    <dei:EntityCentralIndexKey
      contextRef="duration_2023-11-08_to_2023-11-08"
      id="Hidden_dei_EntityCentralIndexKey">0001107421</dei:EntityCentralIndexKey>
    <dei:DocumentType contextRef="duration_2023-11-08_to_2023-11-08">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="duration_2023-11-08_to_2023-11-08">2023-11-08</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName contextRef="duration_2023-11-08_to_2023-11-08">Alaunos Therapeutics, Inc.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="duration_2023-11-08_to_2023-11-08">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber contextRef="duration_2023-11-08_to_2023-11-08">001-33038</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber contextRef="duration_2023-11-08_to_2023-11-08">84-1475642</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="duration_2023-11-08_to_2023-11-08">8030 El Rio Street</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown contextRef="duration_2023-11-08_to_2023-11-08">Houston</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="duration_2023-11-08_to_2023-11-08">TX</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="duration_2023-11-08_to_2023-11-08">77054</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="duration_2023-11-08_to_2023-11-08">(346)</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="duration_2023-11-08_to_2023-11-08">355-4099</dei:LocalPhoneNumber>
    <dei:WrittenCommunications contextRef="duration_2023-11-08_to_2023-11-08">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial contextRef="duration_2023-11-08_to_2023-11-08">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer contextRef="duration_2023-11-08_to_2023-11-08">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer contextRef="duration_2023-11-08_to_2023-11-08">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle contextRef="duration_2023-11-08_to_2023-11-08">Common Stock, par value $0.001 per share</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="duration_2023-11-08_to_2023-11-08">TCRT</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="duration_2023-11-08_to_2023-11-08">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany contextRef="duration_2023-11-08_to_2023-11-08">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>10
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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MWR-PP.WB@[_$"#@OCXZ.7DD9[Z5ZT0ECAKQFJ= 3)S$FOW%='24LH_I*YDS
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MKW#.RW^0\Y^M<\TUMTQ>DO:C_S=7^2V,D_'T7!S1JP,Z6PE<A!OZ%>Y7>>9
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M)$WS/(X %F>0IA@"IQ%', ;  4/2='@//GL?)=-[*CG_5U/\!%!+ P04
M"  //6Y7EXJ[',     3 @  "P   %]R96QS+RYR96QSG9*Y;L,P#$!_Q=">
M, ?0(8@S9?$6!/D!5J(/V!(%BD6=OZ_:I7&0"QEY/3P2W!YI0.TXI+:+J1C]
M$%)I6M6X 4BV)8]ISI%"KM0L'C6'TD!$VV-#L%HL/D N&6:WO606IW.D5XA<
MUYVE/=LO3T%O@*\Z3'%":4A+,P[PS=)_,O?S##5%Y4HCE5L:>-/E_G;@2=&A
M(E@6FD7)TZ(=I7\=Q_:0T^FO8R*T>EOH^7%H5 J.W&,EC'%BM/XU@LD/['X
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M%_\;SO$1PNZ_/[&\UDX:?^:+X3]>?P%02P$"% ,4    "  //6Y7!T%-8H$
M  "Q    $               @ $     9&]C4')O<',O87!P+GAM;%!+ 0(4
M Q0    (  \];E=U5J\;[@   "L"   1              "  :\   !D;V-0
M<F]P<R]C;W)E+GAM;%!+ 0(4 Q0    (  \];E>97)PC$ 8  )PG   3
M          "  <P!  !X;"]T:&5M92]T:&5M93$N>&UL4$L! A0#%     @
M#SUN5_QB],51!   E!   !@              ("!#0@  'AL+W=O<FMS:&5E
M=',O<VAE970Q+GAM;%!+ 0(4 Q0    (  \];E>?H!OPL0(  .(,   -
M          "  90,  !X;"]S='EL97,N>&UL4$L! A0#%     @ #SUN5Y>*
MNQS     $P(   L              ( !< \  %]R96QS+RYR96QS4$L! A0#
M%     @ #SUN5QPX9>H_ 0  / (   \              ( !61   'AL+W=O
M<FMB;V]K+GAM;%!+ 0(4 Q0    (  \];E<D'INBK0   /@!   :
M      "  <41  !X;"]?<F5L<R]W;W)K8F]O:RYX;6PN<F5L<U!+ 0(4 Q0
M   (  \];E=ED'F2&0$  ,\#   3              "  :H2  !;0V]N=&5N
B=%]4>7!E<UTN>&UL4$L%!@     )  D /@(  /03      $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>12
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.23.3</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>22</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>0</UnitCount>
  <MyReports>
    <Report instance="d349273d8k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>100000 - Document - Document and Entity Information</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://alaunos.com//20231108/taxonomy/role/DocumentDocumentAndEntityInformation</Role>
      <ShortName>Document and Entity Information</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" isOnlyDei="true" original="d349273d8k.htm">d349273d8k.htm</File>
    <File>tcrt-20231108.xsd</File>
    <File>tcrt-20231108_lab.xml</File>
    <File>tcrt-20231108_pre.xml</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="22">http://xbrl.sec.gov/dei/2022</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>15
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "d349273d8k.htm": {
   "nsprefix": "tcrt",
   "nsuri": "http://alaunos.com/20231108",
   "dts": {
    "inline": {
     "local": [
      "d349273d8k.htm"
     ]
    },
    "schema": {
     "local": [
      "tcrt-20231108.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd",
      "http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://xbrl.sec.gov/dei/2022/dei-2022.xsd",
      "https://xbrl.sec.gov/naics/2022/naics-2022.xsd"
     ]
    },
    "labelLink": {
     "local": [
      "tcrt-20231108_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "tcrt-20231108_pre.xml"
     ]
    }
   },
   "keyStandard": 22,
   "keyCustom": 0,
   "axisStandard": 0,
   "axisCustom": 0,
   "memberStandard": 0,
   "memberCustom": 0,
   "hidden": {
    "total": 2,
    "http://xbrl.sec.gov/dei/2022": 2
   },
   "contextCount": 1,
   "entityCount": 1,
   "segmentCount": 0,
   "elementCount": 23,
   "unitCount": 0,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/dei/2022": 22
   },
   "report": {
    "R1": {
     "role": "http://alaunos.com//20231108/taxonomy/role/DocumentDocumentAndEntityInformation",
     "longName": "100000 - Document - Document and Entity Information",
     "shortName": "Document and Entity Information",
     "isDefault": "true",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "duration_2023-11-08_to_2023-11-08",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "p",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d349273d8k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "duration_2023-11-08_to_2023-11-08",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "p",
       "div",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "d349273d8k.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "dei_EntityAddressCityOrTown": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "localname": "EntityAddressCityOrTown",
     "presentation": [
      "http://alaunos.com//20231108/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, City or Town",
        "terseLabel": "Entity Address, City or Town",
        "documentation": "Name of the City or Town"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityIncorporationStateCountryCode": {
     "xbrltype": "edgarStateCountryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "localname": "EntityIncorporationStateCountryCode",
     "presentation": [
      "http://alaunos.com//20231108/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Incorporation State Country Code",
        "terseLabel": "Entity Incorporation State Country Code",
        "documentation": "Two-character EDGAR code representing the state or country of incorporation."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine1": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "localname": "EntityAddressAddressLine1",
     "presentation": [
      "http://alaunos.com//20231108/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Address Line One",
        "terseLabel": "Entity Address, Address Line One",
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "localname": "EntityFileNumber",
     "presentation": [
      "http://alaunos.com//20231108/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity File Number",
        "terseLabel": "Entity File Number",
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://alaunos.com//20231108/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Central Index Key",
        "terseLabel": "Entity Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_DocumentPeriodEndDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "localname": "DocumentPeriodEndDate",
     "presentation": [
      "http://alaunos.com//20231108/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period End Date",
        "terseLabel": "Document Period End Date",
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressStateOrProvince": {
     "xbrltype": "stateOrProvinceItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "localname": "EntityAddressStateOrProvince",
     "presentation": [
      "http://alaunos.com//20231108/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, State or Province",
        "terseLabel": "Entity Address, State or Province",
        "documentation": "Name of the state or province."
       }
      }
     },
     "auth_ref": []
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "localname": "PreCommencementIssuerTenderOffer",
     "presentation": [
      "http://alaunos.com//20231108/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre Commencement Issuer Tender Offer",
        "terseLabel": "Pre Commencement Issuer Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "dei_CityAreaCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "localname": "CityAreaCode",
     "presentation": [
      "http://alaunos.com//20231108/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "City Area Code",
        "terseLabel": "City Area Code",
        "documentation": "Area code of city"
       }
      }
     },
     "auth_ref": []
    },
    "dei_SecurityExchangeName": {
     "xbrltype": "edgarExchangeCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "localname": "SecurityExchangeName",
     "presentation": [
      "http://alaunos.com//20231108/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Exchange Name",
        "terseLabel": "Security Exchange Name",
        "documentation": "Name of the Exchange on which a security is registered."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityAddressPostalZipCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "localname": "EntityAddressPostalZipCode",
     "presentation": [
      "http://alaunos.com//20231108/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address, Postal Zip Code",
        "terseLabel": "Entity Address, Postal Zip Code",
        "documentation": "Code for the postal or zip code"
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "localname": "DocumentType",
     "presentation": [
      "http://alaunos.com//20231108/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Type",
        "terseLabel": "Document Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityTaxIdentificationNumber": {
     "xbrltype": "employerIdItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "localname": "EntityTaxIdentificationNumber",
     "presentation": [
      "http://alaunos.com//20231108/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Tax Identification Number",
        "terseLabel": "Entity Tax Identification Number",
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityEmergingGrowthCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "localname": "EntityEmergingGrowthCompany",
     "presentation": [
      "http://alaunos.com//20231108/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Emerging Growth Company",
        "terseLabel": "Entity Emerging Growth Company",
        "documentation": "Indicate if registrant meets the emerging growth company criteria."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_LocalPhoneNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "localname": "LocalPhoneNumber",
     "presentation": [
      "http://alaunos.com//20231108/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Local Phone Number",
        "terseLabel": "Local Phone Number",
        "documentation": "Local phone number for entity."
       }
      }
     },
     "auth_ref": []
    },
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://alaunos.com//20231108/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Flag",
        "terseLabel": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "dei_TradingSymbol": {
     "xbrltype": "tradingSymbolItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "localname": "TradingSymbol",
     "presentation": [
      "http://alaunos.com//20231108/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Symbol",
        "terseLabel": "Trading Symbol",
        "documentation": "Trading symbol of an instrument as listed on an exchange."
       }
      }
     },
     "auth_ref": []
    },
    "dei_SolicitingMaterial": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "localname": "SolicitingMaterial",
     "presentation": [
      "http://alaunos.com//20231108/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Soliciting Material",
        "terseLabel": "Soliciting Material",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "dei_CoverAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "localname": "CoverAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Cover [Abstract]",
        "terseLabel": "Cover [Abstract]",
        "documentation": "Cover page."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://alaunos.com//20231108/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Registrant Name",
        "terseLabel": "Entity Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_WrittenCommunications": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "localname": "WrittenCommunications",
     "presentation": [
      "http://alaunos.com//20231108/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Written Communications",
        "terseLabel": "Written Communications",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    },
    "dei_Security12bTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "localname": "Security12bTitle",
     "presentation": [
      "http://alaunos.com//20231108/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security 12b Title",
        "terseLabel": "Security 12b Title",
        "documentation": "Title of a 12(b) registered security."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "dei_PreCommencementTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2022",
     "localname": "PreCommencementTenderOffer",
     "presentation": [
      "http://alaunos.com//20231108/taxonomy/role/DocumentDocumentAndEntityInformation"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre Commencement Tender Offer",
        "terseLabel": "Pre Commencement Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b"
  },
  "r1": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r2": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r3": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r4": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r5": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Section": "14a",
   "Number": "240",
   "Subsection": "12"
  },
  "r6": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "425"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>16
<FILENAME>0001193125-23-276662-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001193125-23-276662-xbrl.zip
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M[T,!63\$)<R6'4.+_M:V*^GT3F^GC4'-VRY-Y3N@XT+3<9G3D4>LTTAGS#+
MC]B9]'IAY[M>>\O?WNIN;QUMS\%$"+WXMODN@WXA9UI1Q'>TD(J#JP)6)7J3
MD'D1H^XNB)R&#$W3BADXAOE\2'Y,0ZOM7:/M573@9R$*! B,D!"%31F!YQ/%
MMQ>R9RX /3F^ [C^8QK9(-KI++)FO>?:[&A-G+,RN,>ZP)%KGJEN;N3+%,OB
M)]MD0&.>0!O[L,ABYR-S[=%D.ZGL.*IM3]K,-<4S5JYO9 X7E4)O [Y%QX;@
MS'@"+; HLA@N$YA[;UZS(!C<<(ST:&2@71B)\5V8S*Q:68TK*E?1FQK^]V8
MJ2U1S2G\GT_5%G[BI#)V:)=?B+7'#.('N#D#.&TX*;*JHFGF_S.M-#TO"P=#
MYE-7)$37BZT6^OQ<YU$5C'L&%^\573,V]\HA)3%K+]K5D " L*6B6MKU N5C
M79(W4[1[S5,5LRC(^EUDE'B@SUC(2I=>]+I;G'/0,38:H4D [3/Y_5LG1C0A
M3-5 =.LEMIV=QOG5B4MM,WTM9 ;890;M\Z.K961P,L@DK UA(FY9A4MR^F$J
M X7T9>%6YE6)8QU>"Q$7E/0']#Z<ZN#+5*(75L#+,' &5B95"HUYCY/&#XRB
M2BAR02,6EJ:K[^2>\+FM^%=FSSAH]UV:*Y _-G034T/5TS4SP,D9+BQC 8H%
M\C2,$<O[@@05/\09@+(&N*@%S^_0XT'^JAC[9/4 '2(.!&V,LX4V:(\Z+8,F
M:)#I!+<,PW!:%4 E?!/EJ';_^A@/@U2D"2KM3E\@)98X_?P&5QE84/9C9AJJ
M3+8N9<%8=W:3?<!\?8S#1"=-?F;6I;6ZLJ/!=N7I9:;]_ IQ-*L%.@IFT@.$
M!]*5W.3=4\,0XZV4K9$$; F4J!,E*AAK _H\;QS0M9 E8#,P=P9JY+:O]%)X
M!CL&E]>NZ@3N*V3NY!"J,> &'TV? [($:UA4/7B.XAQHLP\>!NPA @L#]9(Z
M9!294\I*XI!&ADGP"@!P+';J^DZNISJV:2 T(AS7AF<0CWO9&M$2X)&?UG.<
M=X(NI"8*<H$%P8HKJQ=H6$"&+](0TQ\R06<0<#SMFH8Z@@W3*1*M6!@N"'H2
MFX@AEL-PPK@6RL@?J4A,ONF0'[.A?5'@-&.K%+?#@FIG9PS ?'%-JUGP9Z8I
M#4%I.?"++\X-7<$0V4>Q..4;C6RZQ:;"6I9>U/G[+F@]VP'[VB& ECLJ@\:9
M$)]0EE>NI*F66'95^65#0_Z\Y8%\W[$N^ZJL<&YG%-H9945:E?DUL%5NG..$
MT:C@A']I7C7)B(%KI!A4,U 4TCN%T;"J9^>/LL]>:_=R)W Y7-=::48>^% L
MI*NZH\;>G]#I["WT.K/WM*W--5QT4XT7W06PSB&VSPUO(\SL;0CR' _=)PO>
M ..?+'I@H-+<;?3"\S<%?C@?_,K< T"NX"3<771U'/2(RKPHK]"5C-($ZY F
MQ009G=Q3_-"[7B6IUH1LA6!C;3/K"*RNE4BD"7CW"3=NM5X< ".$U%G)#*3)
MXTF.(+'JB%LLEF-EY[.![065=4L&(UW8_[P<Y&2P5,D11A8N=;S%>[AZ LQ,
MA,3:-1E15"2X*_/@;.21R4HOVL!M+(E!M*,&1TYU;_CQ^\"!E[D"H_476HU'
MJFZ146&%&(><Q.8Z%X+FE!D>OXL$U+OZ9CTC2^MG!HGQJQ+65EW(=*80F,^H
MFO$2J97=[*P!7R0F4WW?+.#8OK/E6=#0[VR6O40[)0LQ8-M:D>FCP*'"6AR/
M$ [A)UVY^F0(2H&O$CUBHN>@>>(G*0VS96%P-1I, 'TNK -2M84"@8M]3"-:
M4 OK)JMI!0E.T'5C8HV"%](JA@$%9JHSXP/==OBEUI1#9$V:15-(/ WP[]8@
M_D:\@9RP%0 >S0,99S8K\8A=38]N]DNVBG6'/$=3-H?*L#9,(47G=!/I>CZP
M(11*,;6_<-"(,;/+JE O&Z4:2M?MIF.<H%V/I+<47!Y"29@-P!H%[34"!:^@
MT">B 8;A?C9'HW1\3B(!4[[D0YT3.MP/\$N[%>MP+T&!R'O3WGE=OM@(?T[U
MUTN!_9N&;:_=^#G[?H"M)_V1]68KTTNW)-1UM24H.2V="5;LOT#.H+E;<]3.
M4LVXO"-<>:W2<)!'P%RRX'3BX>%#9?X-)BRB\@*V<6[P(!>\WB4 R1<8MWZ%
M*N?X _WI.;=572<MFE:,@6XEV*8<&HT4$A. ,W.)NUTGULM>E$^4^0A#_JT&
M4/4XA4L?&J6Q'IPNXYNJ9Y'/9?ZXK W JFX<!.HYIC;(7N-[ "&Z DO^,EJ?
M]1PX<]R*6.!9YKT#<,FAB(W_+.Y<>%W??N+U[;UFV_O3+F_G^\D*B8\IP.I=
M(NIQUJ4W2HRV@NV9X1=K;^>I3P ^CG:O<000<VQ[#-#^" S+W=4Z!_9VEAW8
MVWNV WM6[VUM8.8PY>,<SUMAFE9WG$WJ(TTK7CD7BW:HK'.:I?),RX-.&Z[E
M =;@)7%_6TWK>P/U^[,.D.%WFA%!Q>[+KKDJY;J[P$3GSW6Y;U'ADP5<*SP&
ME(E&"KK4>>:O;L^[Z85RPPUT3Z4NYH03)>8/M07=WE[G;3=@]WM[7G.<3/0I
M=*4 ?YJMJ  ,JC?:UC54"BH@(GI86LG?OXLLO7;O244Y -Y+<@$S!)& 8Z1F
M5?68)I3H3^)NH6B"P")[FWB<ZK\=2?"/1V9;(?%X4FY[63A^K1^_1/UXX5\Y
M._W^_.CZE\N3ARP-;024+LJ;8DL++&MOB<9&E^5S4T$*.8ZN7 0FS3,?,'1K
ML#!94Z#2920VIN'(Y8<ZN[8-L#"3XL9>W1W(9BPD3"SX:T*ZA2"NK-2][&L.
MF\"ZI=]AV*S')1WM/#YIO1+BG(<)S^'NE\Q[TS/*J\_P;YB^S:CRDY&8Q][N
M2NB\["\.+?U[".O@!+3N94!!/Y]'"D_5]H40B),B[AOM5V"ROZ6Z:ISTW;3_
M+)-?XWL;*XZA;ABK6ZI%/C" <P$E9]3_Q*;/_DF-5]\XHVSX88@G5+=9<;^*
M^N5$K;_Z\H2ROF(1%Y+\&W<386JN-T+4R1F[P:\$1 $Y"O"LAMMZNFX*=] :
MBF *=R#G#P__#U!+ P04    "  //6Y7U<]&:PP8   (@0  $0   &0S-#DR
M-S-D97@Y.3$N:'1M[5UI4QO)EOU.!/\A@[9?0(0D2^R;B9&!MHG!P(#</6^^
MI:I24K5+E>I:P/2OGW-O9M8B)#8+C)]Y\:)MU9)Y\^:Y^\WR[J?.Y^.]W4^'
M[8.]^;G=SE'G^'#O\'_K6UN-UNX[\Q/7W]D'Q.Z'TX-_BP\?]T^/3\_?+_SY
MZ:ASN" N.O\^/GR_$ :1J@]4T!^DVR<Z'LIP84_,S^']?16E*M[;/3CZPSU\
M%?CI8'NSL19$"T*&03_" *J7+M T1$K[P_&AV#\\/KXX:^\?G7Q\O]!<X-]G
M[8,#]_O/HX/.I_<+K6;S[8+X<'I^<'C.U^TDYDH=U!ZWSRX.M]U?=D1/1VF]
M)X=!>+W="88J$2?J2ISKH8SLS23X1VVWFJ-T0;2/CSZ>O%_P>!5$H"7QW-%Z
MX A9:[U=V /C#HH[?]BWNSI-]; @V3U8'6!UTUW'?\Y+4[DEC61?U;NQDE_K
M090$OMJ6ESKPQ<.6M#=&7*I'9EVX?/3YH[@XWW^_T%]9W5K>6.FW6JW5YMK*
MVFIS:WVY\=>H3QSIO%\X/OUXNL#P*)8QMMJ]?T7=9+1C_GO+<X[%,8$'#/BP
M=_AM$'2#5!@D?JCP!'\0.O;$[IECRU#&_2"J8QW;RZNC=$?8"V;\[29=JO+@
M5H;=V'-0U YE%NE$= 8JEB.5I8&7B'84Z2SR%%T.8E_\3R9CO""6F\LKXO<@
MDI$7R%"<JR0+TZ0FS@8R4:(E]B$L@8<[!S*50D:^V <U090I?W[N\-LHU+%,
M QT)W1,7*?ZN^H$GVB'&CG#C$A,:KIR5N5!:X3)66&)*L_A9L,1M#X^2R]QL
M9:<DE./".R[<96'>LZA/TNM0B?=B&NX7QN1G[6VQJ!O"M0(E44:\VV2C=_[U
M6VMU:])KK;'7)DQ0'JCZ+.U.Y:YEKZANCIB.V/N*].[17F?_O-X1QT$WEO&U
MP]J[99'&!$+I#0)UJ7S 36QNO!5^D"AZPL- L0X%H8SPQAI<J$L99K(+[H\
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M(&^'&\2\!ZF]R\_U53W7E,K/8YIQW] R9&6,(51*(,E:JU['G[#D)A2_9KI
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MLL=YW6Y?J_X&L^TKW.T,KWJ[U8X:^OD?4$L#!!0    (  \];E?4:FB,7 8
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MGG\P5A2"K!+DI9 ^XVO1AN%#/ELOY1U7:DO_WHE\%\U^^X+:\Q]02P,$%
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M]O]+]30>'[\LOA2ANO1><NTH^K.?LI--5^LYJ/_.LB2.-T1+O&^XGONSL3*
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M   1              "  :8O  !T8W)T+3(P,C,Q,3 X+GAS9%!+ 0(4 Q0
M   (  \];E?4:FB,7 8  +]#   5              "  1(S  !T8W)T+3(P
M,C,Q,3 X7VQA8BYX;6Q02P$"% ,4    "  //6Y7S,-WO[($  !S*@  %0
M            @ &A.0  =&-R="TR,#(S,3$P.%]P<F4N>&UL4$L%!@     %
-  4 0 $  (8^      $!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
